|
|
|
05.01.26 - 09:42
|
MiniMax′s Hong Kong IPO set to hit US$538 million amid Chinese AI sector frenzy (SCMP)
|
|
|
MiniMax is set to raise at least HK$4.2 billion (US$537.7 million) by pricing its Hong Kong initial public offering (IPO) at the top of its marketed range, underscoring strong demand for China's artificial intelligence sector amid an intensifying race with the US.
The Shanghai-based firm, backed by Alibaba Group Holding and Tencent Holdings, planned to price its 25.4 million shares on offer at HK$165 each, according to people familiar with the matter. The company would stop taking orders from......
|
|
|
|
|
|
|
05.01.26 - 06:15
|
After carving out a place in the laser cutter market, xTool eyes Hong Kong IPO (Bamboo Works)
|
|
|
The leading maker of laser cutters and engravers boasts Tencent and HongShan as two of its backers, as well as Morgan Stanley as one of its IPO underwriters Key Takeaways: By Doug Young When it comes to new IPOs, tech companies are always trying to sell themselves on their cutting-edge technology. But xTool Innovate.....
The post After carving out a place in the laser cutter market, xTool eyes Hong Kong IPO appeared first on Bamboo Works....
|
|
|
05.01.26 - 06:06
|
China memory makers′ IPO line up: CXMT seeks US$4.2 billion, YMTC prepares filing (Digitimes)
|
|
|
Strong AI demand has pushed the memory sector into a rare upcycle. China's leading DRAM maker CXMT is advancing an IPO application on the STAR Market, targeting CNY29.5 billion (US$4.21 billion), the second-largest fundraising in STAR Market history. In parallel, supply chain sources say China's NAND flash leader YMTC is likely to file for an IPO in the first half of 2026....
|
|
|
|
|
05.01.26 - 05:48
|
Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO (SCMP)
|
|
|
Newly Hong Kong-listed biotech firm Insilico Medicine is expected to receive up to US$888 million from a French drug maker under a partnership using Insilico's proprietary artificial intelligence platform to discover and develop novel cancer drugs.
The deal comes just days after the US company's shares debuted following its initial public offering (IPO), which raised HK$2.28 billion (US$293 million) after the public portion was oversubscribed 1,427 times.
The multi-year partnership with Servier,......
|
|
|
|
|
05.01.26 - 04:06
|
The ′biology winter′ thaws: why investors are piling into Hong Kong′s biotech IPOs (SCMP)
|
|
|
Hong Kong's biotech fundraising momentum is expect to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China's drug developers are worth backing again – even before they generate revenue.
“Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation sector has entered its harvest phase,” said Felix Huang, head of equity at Oakwise Capital. “New trends......
|
|
|
|
|
|
|
|
|
04.01.26 - 07:06
|
Turning point: China doubles IPOs in 2025 amid eased curbs to drive tech innovation (SCMP)
|
|
|
Initial public offerings (IPOs) in mainland China nearly doubled in 2025 from a year earlier after the securities regulator rolled back curbs on new listings and resumed approvals for pre-profit technology companies, in line with Beijing's drive to replace imported tech products with home-grown alternatives.
A total of 115 companies raised a combined 128 billion yuan (US$18.3 billion) from IPOs on the Shanghai, Shenzhen and Beijing exchanges this year, according to Bloomberg data.
That eclipsed......
|
|
|
|
|
|
|
|
|
02.01.26 - 18:01
|
LandSpace Wins Nod for $1 Billion IPO Amid China′s Space Ambitions (Caixin)
|
|
|
Chinese private rocket company LandSpace Technology Co. Ltd. has received the green light to list on Shanghai's STAR Market, marking a potential first for China's fledgling commercial space sector. The company aims to raise 7.5 billion yuan ($1.1 billion) through the offering.
... Read more...
|
|
|
|
|
|
|
02.01.26 - 14:01
|
Feststoffbatterie-Entwickler Factorial will durch SPAC-Fusion an die Börse (Electrive)
|
|
|
Mit Factorial Energy geht ein weiterer Batterieentwickler an die US-Technologiebörse Nasdaq. Wie zuvor schon StoreDot wählt auch Factorial dafür den Weg über einen Zusammenschluss mit einem SPAC, also einer leeren Börsenhülle. Ziel ist es, die Kommerzialisierung der Feststoffakku-Technologie von Factorial zu beschleunigen....
|
|